Mutations in genes encoding Wilms tumor 1 (WT1), nucleophosmin (NPM1), FMS-like tyrosine kinase-3 (FLT3), and CCAAT/enhancer-binding protein alpha (CEBPA) affect the pathogenesis of AML [3]. This evidence concerns the gene WT1 and acute myeloid leukemia.